Arda Therapeutics’ Post

SFBN Feed: Insights from new CEOs: Rachael McKinney, greater Sacramento market president, Sutter Health https://lnkd.in/gXRwbcDB Heading into a new year, new leaders are stepping up in the Sacramento region. One of those is Rachael McKinney, greater Sacramento market president for Sutter Health. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News

Personally I think this is a solid choice of investment by Purpose Ventures and i will share you my thoughts on this. A growing trend in healthcare will be; -real world evidence based research/drug development -potentially to utilise and leverage off ai-driven to further boost data gathered from real world evidence leading to quicker lead time for drug development or research -bespoke, this is the next big trend in advancement of medical treatment will be a tailored to each individual We can see even on outside of the private equity space, companies like Emyria (ASX:EMD) is backed by Tenmile on solely those trends alone. I never knew there is many australian companies who are in the forefront of bio-tech and lets not forget, the benefits of RnD too, i think is somewhere on 43.5% which is relatively high to foster innovation. Nevertheless great and solid choice for the long run Derek Gerrard Kylie Gerrard seeing some 🔥 action for the fund.

Many of you ask me about the story behind our Brand and Company Name: PurposeBio. Here It is, I hope you'll like it: After 20 wonderful years in #tech #saasgrowth #B2B, I decided it was time to leverage my skills for a good #Purpose. A Purpose that will bring good to humans around the world. I think turning 40 definitely had a lot to do with it. And also, losing my most amazing Dad changed the perspective on everything in life.  Thanks to an amazing EIR experience I had at SRI International, I came across my Co-Founder's scientific articles Elaine Hsiao, and immediately fell in love.  I knew Nothing about #pharma, #drugdevelopment or #biotech. I just knew that I wanted to bring something to the world that will make humans happier and healthier.  I approached UCLA's Amir Naiberg to discuss some ideas I had and the rest is history. Fast Forward: we started a new venture and named it PurposeBio. Purpose for 2 reasons:  ONE - We are working and are #driven with and for a Purpose. TWO - Our #drug’s #biology and #science are driven from the original Purpose of our body's #phenomenal #mechanisms. The deep color RED represents a vibrant healthy RED, as we aim to help people around the world have a vibrant and healthy life. We had a sweet #win recently, when the USPTO granted us our rights for our #Trademark: Purpose Bio along with rights to our beautiful #logo which symbolizes our #syntheticbiology #innovations.  We have so many scientific wins and milestones we meet, which I cannot share (yet). But this one is fun and represents a journey I am so profoundly proud of, along a team I admire and learn from every day.  So - Mazal Tov to us for that official granting of our trademark Purpose Bio!  I can't wait to share more wins with all of you, for the better of all of us! #startup #therapeutics #cardiometabolic #unmetneeds #lifescience Eran Elinav Jonathan Lynch

I was delighted to have had the opportunity to represent Accelagen last week at AusBiotech, Australia's premier biotech conference! 🌐 One of the highlights was attending a talk by Emeritus Professor Ian Frazer, the brilliant mind behind the revolutionary Gardasil® vaccine. The groundbreaking work by him and his team has had a profound impact on public health, not only in Australia but globally. It's a testament to the incredible contributions that Australian scientists are making on the world stage. 🦠 Professor Frazer's vision and experience were both inspirational and thought-provoking, sharing insights on navigating the future of biotech in Australia, offering predictions and discussing the immense potential that the Australian biotechnology sector holds. 🚀 His presentation was a compelling exploration of how innovation, research, and collaboration are shaping the landscape - It's evident that Australia's biotech industry has a bright future, with the potential to be a global leader. 🧬 Accelagen, as a dynamic player in this arena, is committed to being part of this exciting journey. We're dedicated to advancing healthcare solutions, fostering collaborations, and contributing to the growth and success of Australian biotechnology. 💡 I'm excited to bring back Professor Frazer's wisdom and the inspiration from AusBiotech to Accelagen, as we continue to drive innovation and shape the future of biotech in Australia. Together, we're on the path to transformative discoveries that will improve lives and redefine the industry. 🌟 #AusBiotech #BiotechFuture #Innovation #Accelagen #AustralianBiotechnology #HealthcareInnovation”

Founder Spotlight 🚀: Introducing the distinguished minds steering Imagine Biotech: Dr. Joseph Nowoslawski, a seasoned biotech investor, medical practitioner and accomplished healthcare executive, alongside Michael Savvides, an innovative entrepreneur and renaissance man. United in purpose, they have embarked on a transformative journey, aimed at reshaping the biotech sphere by addressing the formidable expenses entwined with the molecular compatibility of the technological or therapeutic hypothesis of a new drug candidate. Their collaborative endeavors signal a shift in paradigms, introducing an innovative solution positioned to transform the complex terrain of predicting a drug candidates’ efficacy, often costing investors millions of dollars through the various phases of trials. #biotech #biotechnology #venturecapital

🔬 Celebrating the Success of BIO Europe Conference 2023 in Munich Germany! (Next stop BIO Intl Convention Boston June 3-6 2024 ☀️San Diego.) Thrilled to have been part of the vibrant discussions and groundbreaking insights at the BIO Europe Conference. It showcased the incredible strides in biotech innovation that are shaping the future of healthcare. Biotech isn't just about science; it's about transforming lives. The innovations discussed here have the power to revolutionize medicine, addressing unmet needs and improving patient outcomes. As we navigate a rapidly evolving world, the significance of biotech innovation has never been clearer. Investing in biotech means investing in a healthier, more sustainable future. It's a catalyst for progress, driving advancements that impact us all. Let's continue to support and champion biotech innovation—it's not just a field; it's a lifeline to a better tomorrow. Thanks to all the Team at Informa, EBD Group, Sponsors and Biotechnology Innovation Organization 🧬💡 #bioeurope #healthcarerevolution

Save the date! 📅 On October 24th at 10:00 AM PST/ 1:00 PM ET, Element CEO and Co-founder Molly He is joining Veracyte, Inc. Co-founder and Pink Dx CEO Bonnie Anderson for an in-person fireside chat on innovation and women’s health. In this wide-ranging discussion, Molly and Bonnie share their insights on their roles as female founders and the kind of bold innovation needed for improving health. Follow us here for real-time updates -- you don’t want to miss it! #Genomics #ElemBio #BioTech #Leadership #WomenInSTEM #LifeSciences

ROSEAId Inc., Welcomes Joseph Rossi as CEO! Joseph Rossi brings visionary leadership and decades of experience, including serving on Boards of Directors and Advisory Councils, to his role as CEO of ROSEAId Inc. Driven by his passion for leveraging technology, he is excited and aims to enhance the overall healthcare experience for patients and providers alike. To learn more, please refer to the attached press release below! #ROSEAId #biomedical #leadership #digitaltransformation #biotechnology #telepathology Russell Raff Harvey Rand Eli Zukovsky Pete Beausoleil Venkat Iyer Jen Flaherty Baxter J Garcia, Ph.D.

From its humble beginnings in 1996 to becoming a beacon of innovation, VIB emerged as a strategic research center with a mission to propel the life science ecosystem forward 🧬 And it did just that One of the most respected global leaders in Biotech, entrepreneur Johan Cardoen talks about the strategic heartbeat of Belgium's life science industry in our latest #LeadersOnAMission episode Join us for an insightful conversation as we delve into the foundational journey of VIB (Flemish Institute for Biotechnology) And its pivotal role in shaping Belgium's life science landscape 👏👏 Listen to the full episode via the links in the comments 👇 #biotech

🚀 Exciting news! 🚀 Thrilled to announce that I'll be sharing insights on a panel discussion at BioFIT in Marseille next week! 🌐 Join me as we delve into the dynamic world of biotech spin-outs and explore the fascinating journey "From lab to start-up." 🔬 Panel Topic: "From Lab to Start-Up: Let’s hear about successful spin-out journeys" 🌱 Navigating the spin-off roadmap: join me and fellow life science professionals as we unravel the strategies and lessons learned from successful biotech spin-outs. We'll be tackling crucial questions: 🔍 License or Launch: How do you decide whether to license a technology to an existing company or take the plunge and set up a spin-off? Let's explore the key considerations and decision-making factors. 🔄 The spin-off blueprint: What are the critical steps and challenges in spinning out a company based on academic research? Get ready for a deep dive into the intricacies of transforming groundbreaking research into a thriving start-up. Looking forward to a dynamic discussion! See you in Marseille! 👋🔬✨ #BioFIT #biotech #lifesciences #innovation #startupsuccess #spinoff